266 related articles for article (PubMed ID: 1527228)
1. Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial.
Modigh K; Westberg P; Eriksson E
J Clin Psychopharmacol; 1992 Aug; 12(4):251-61. PubMed ID: 1527228
[TBL] [Abstract][Full Text] [Related]
2. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia.
Bakish D; Hooper CL; Filteau MJ; Charbonneau Y; Fraser G; West DL; Thibaudeau C; Raine D
Psychopharmacol Bull; 1996; 32(1):135-41. PubMed ID: 8927663
[TBL] [Abstract][Full Text] [Related]
3. The use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial.
Bandelow B; Broocks A; Pekrun G; George A; Meyer T; Pralle L; Bartmann U; Hillmer-Vogel U; Rüther E
Pharmacopsychiatry; 2000 Sep; 33(5):174-81. PubMed ID: 11071019
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of the effect of alprazolam, imipramine and placebo in the treatment of panic disorders in Cali, Colombia].
León CA; De Arango MV; Arevalo W; Calvo A; Montoya A; León A
Acta Psiquiatr Psicol Am Lat; 1990; 36(1-2):59-72. PubMed ID: 2073024
[TBL] [Abstract][Full Text] [Related]
5. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
[TBL] [Abstract][Full Text] [Related]
6. Diazepam versus alprazolam for the treatment of panic disorder.
Noyes R; Burrows GD; Reich JH; Judd FK; Garvey MJ; Norman TR; Cook BL; Marriott P
J Clin Psychiatry; 1996 Aug; 57(8):349-55. PubMed ID: 8752017
[TBL] [Abstract][Full Text] [Related]
7. Fluoxetine in panic disorder: pharmacologic and tritiated platelet imipramine and paroxetine binding study.
Pecknold JC; Luthe L; Iny L; Ramdoyal D
J Psychiatry Neurosci; 1995 May; 20(3):193-8. PubMed ID: 7786880
[TBL] [Abstract][Full Text] [Related]
8. Reversible monoamine oxidase-A inhibitors in panic disorder.
Bakish D; Saxena BM; Bowen R; D'Souza J
Clin Neuropharmacol; 1993; 16 Suppl 2():S77-82. PubMed ID: 8313401
[TBL] [Abstract][Full Text] [Related]
9. Clonazepam in the treatment of panic disorder: a double-blind, placebo-controlled trial investigating the correlation between clonazepam concentrations in plasma and clinical response.
Beauclair L; Fontaine R; Annable L; Holobow N; Chouinard G
J Clin Psychopharmacol; 1994 Apr; 14(2):111-8. PubMed ID: 8195451
[TBL] [Abstract][Full Text] [Related]
10. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
[TBL] [Abstract][Full Text] [Related]
11. Clonazepam and imipramine in the treatment of panic attacks: a double-blind comparison of efficacy and side effects.
Svebak S; Cameron A; Levander S
J Clin Psychiatry; 1990 May; 51 Suppl():14-7; discussion 50-3. PubMed ID: 2186020
[TBL] [Abstract][Full Text] [Related]
12. Double-blind comparison of 30 and 60 mg tranylcypromine daily in patients with panic disorder comorbid with social anxiety disorder.
Nardi AE; Lopes FL; Valença AM; Freire RC; Nascimento I; Veras AB; Mezzasalma MA; de-Melo-Neto VL; Soares-Filho GL; King AL; Grivet LO; Rassi A; Versiani M
Psychiatry Res; 2010 Feb; 175(3):260-5. PubMed ID: 20036427
[TBL] [Abstract][Full Text] [Related]
13. Increased antipanic efficacy in combined treatment with clomipramine and dixyrazine.
Feet PO; Götestam KG
Acta Psychiatr Scand; 1994 Apr; 89(4):230-4. PubMed ID: 7912879
[TBL] [Abstract][Full Text] [Related]
14. Adinazolam-SR in panic disorder with agoraphobia: relationship of daily dose to efficacy.
Carter CS; Fawcett J; Hertzman M; Papp LA; Jones W; Patterson WM; Swinson RP; Weise CC; Maddock RJ; Denahan AQ
J Clin Psychiatry; 1995 May; 56(5):202-10. PubMed ID: 7737960
[TBL] [Abstract][Full Text] [Related]
15. Panic attacks and agoraphobia: low dose clomipramine treatment.
Gloger S; Grunhaus L; Gladic D; O'Ryan F; Cohen L; Codner S
J Clin Psychopharmacol; 1989 Feb; 9(1):28-32. PubMed ID: 2651491
[TBL] [Abstract][Full Text] [Related]
16. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
Charney DS; Woods SW; Goodman WK; Rifkin B; Kinch M; Aiken B; Quadrino LM; Heninger GR
J Clin Psychiatry; 1986 Dec; 47(12):580-6. PubMed ID: 3536889
[TBL] [Abstract][Full Text] [Related]
17. Imipramine and buspirone in patients with panic disorder who are discontinuing long-term benzodiazepine therapy.
Rynn M; García-España F; Greenblatt DJ; Mandos LA; Schweizer E; Rickels K
J Clin Psychopharmacol; 2003 Oct; 23(5):505-8. PubMed ID: 14520129
[TBL] [Abstract][Full Text] [Related]
18. Is buspirone effective for panic disorder?
Sheehan DV; Raj AB; Sheehan KH; Soto S
J Clin Psychopharmacol; 1990 Feb; 10(1):3-11. PubMed ID: 2407755
[TBL] [Abstract][Full Text] [Related]
19. Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships.
Mavissakalian MR; Perel JM
Am J Psychiatry; 1995 May; 152(5):673-82. PubMed ID: 7726306
[TBL] [Abstract][Full Text] [Related]
20. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
Dunner DL; Ishiki D; Avery DH; Wilson LG; Hyde TS
J Clin Psychiatry; 1986 Sep; 47(9):458-60. PubMed ID: 2875064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
